Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.21.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 11,629 $ 5,413
Receivables 398 884
Inventory 218 328
Prepaid expenses and other current assets 816 522
Discontinued operations - current assets 128 181
Total current assets 13,189 7,328
Property and equipment, net 563 618
Operating lease right-of-use asset 72 141
Total Assets 13,824 8,087
Current liabilities:    
Accounts payable 768 1,253
Accrued clinical trials expenses 151 214
Other accrued liabilities 296 319
Operating lease liability, current 76 150
Current portion of long-term debt 572 327
Discontinued operations - current liabilities 1,893 1,960
Total current liabilities 3,756 4,223
Long-term debt 88 332
Total liabilities 3,844 4,555
Stockholders' equity    
Common stock, at amounts paid-in 10 7
Additional paid-in capital 379,890 370,804
Accumulated deficit (369,920) (367,279)
Total stockholders' equity 9,980 3,532
Total liabilities and stockholders' equity $ 13,824 $ 8,087